Intraocular neutralizing antibodies against aflibercept in patients with age related macular degeneration

PURPOSE: To detect immunoglobulins in aqueous humour of AMD patients after repeated administration of intravitreal aflibercept. PATIENTS AND METHODS: Twenty-one patients (age: 77.85 ± 9.21 years) previously treated with intravitreal aflibercept due to wet type age-related macular degeneration (AMD g...

Descripción completa

Detalles Bibliográficos
Autores principales: Gyenes, Andrea, István, Lilla, Benyó, Fruzsina, Papp, András, Resch, Miklós, Sándor, Noémi, Józsi, Mihály, Nagy, Zoltán Z., Kovács, Illés, Kiss, Szilárd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830890/
https://www.ncbi.nlm.nih.gov/pubmed/36627583
http://dx.doi.org/10.1186/s12886-022-02761-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830890/
https://www.ncbi.nlm.nih.gov/pubmed/36627583
http://dx.doi.org/10.1186/s12886-022-02761-9

Ejemplares similares